CBAV.MC CLINICA BAVIERA S.A.

Healthcare · Diagnostics & Research

5 · Fair Momentum 10.0 · Strong At risk

59.20

+1.02%

About the company

Clínica Baviera, S.A., a medical company, provides ophthalmologic medicine services in Spain, Germany, and rest of Europe. The company offers refractive, presbyopia, and cataract surgeries; and oculoplastia, corneal disease, dry eye, strabismus, pediatric ophthalmology, glaucoma, neuro-ophthalmological, disorders, and blepharoplasty treatments. It also provides external and internal consultations, surgery treatments, and rehabilitation services. The company was formerly known as Clínica Oftalmológica Baviera, S.L. and changed its name to Clínica Baviera, S.A. in 2000. Clínica Baviera, S.A. was incorporated in 1992 and is based in Madrid, Spain. Clínica Baviera, S.A. is a subsidiary of Aier Eye International (Europe), S.L.U.

Website

2.65%

54.70%

1.57

949.2M

20.63

2.87

53.14

52-week range

59.2

low 40.1 high 62.0

Dividend deep dive

CLINICA BAVIERA S.A., a Healthcare sector company in Diagnostics & Research, currently offers a dividend yield of 2.67%. This yield sits at the lower end of its 5-year range (low 2.54%, high 5.11%), with a dividend rating score of 5.0. The company exhibits strong price momentum, indicated by a score of 10.0. Its valuation appears rich, reflected in a value score of 3.3.

Dividend history

CLINICA BAVIERA S.A. does not have an established dividend increase streak, showing 0 consecutive years of dividend growth. Over the past three years, the dividend has shown significant growth with a CAGR of 44.9987%. A 5-year dividend CAGR figure is not available. Annual dividends per share have been 0.1 EUR (2013), 0.28 EUR (2014), 0.11 EUR (2015), 0.315 EUR (2016), 0.22 EUR (2017), 0.48 EUR (2018), 0.58 EUR (2019), 0.526 EUR (2021), 0.515 EUR (2022), 0.8 EUR (2023), and 1.57 EUR for both 2024 and 2025.